VITAL INNOVATIONS HOLDINGS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.229 HKD | -11.92% |
|
-.--% | -15.19% |
| Mar. 26 | Vital Innovations Holdings Limited Announces Delay in Publication of the Annual Results for the Financial Year Ended 31 December 2023 | CI |
| 2023 | Vital Innovations Logs H1 Loss | MT |
Valuation
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 279.6 | 492.6 | 269.7 | 336.2 | 200.9 | 177.2 |
| Enterprise Value (EV) 1 | -413.8 | -205.5 | 241 | 303 | 189.6 | 148.6 |
| P/E ratio | -2.55 x | 33.9 x | -48.1 x | -3.44 x | -9.8 x | -10.1 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 1.43 x | 0.54 x | 0.33 x | 0.38 x | 0.3 x | 0.16 x |
| EV / Revenue | -2.11 x | -0.23 x | 0.3 x | 0.34 x | 0.28 x | 0.14 x |
| EV / EBITDA | 8.22 x | 15.9 x | -14.9 x | -2.98 x | -8.58 x | -8.43 x |
| EV / FCF | -1.26 x | 14.6 x | -0.4 x | 7.83 x | -15.5 x | 6.37 x |
| FCF Yield | -79.1% | 6.86% | -247% | 12.8% | -6.46% | 15.7% |
| Price to Book | 0.38 x | 0.67 x | 0.41 x | 0.6 x | 0.37 x | 0.34 x |
| Nbr of stocks (in thousands) | 850,000 | 850,000 | 850,000 | 850,000 | 850,000 | 850,000 |
| Reference price 2 | 0.3290 | 0.5795 | 0.3173 | 0.3956 | 0.2363 | 0.2084 |
| Announcement Date | 4/23/18 | 4/29/19 | 7/9/20 | 4/28/21 | 4/28/22 | 4/26/23 |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net sales 1 | 196.1 | 911.4 | 815.9 | 881.1 | 672.7 | 1,092 |
| EBITDA 1 | -50.32 | -12.93 | -16.14 | -101.7 | -22.08 | -17.62 |
| EBIT 1 | -50.36 | -13 | -16.17 | -101.7 | -22.11 | -17.64 |
| Operating Margin | -25.68% | -1.43% | -1.98% | -11.55% | -3.29% | -1.62% |
| Earnings before Tax (EBT) 1 | -107.7 | 14.55 | -5.574 | -97.61 | -20.57 | -17.56 |
| Net income 1 | -109.7 | 14.55 | -5.574 | -97.62 | -20.5 | -17.55 |
| Net margin | -55.93% | 1.6% | -0.68% | -11.08% | -3.05% | -1.61% |
| EPS 2 | -0.1291 | 0.0171 | -0.006600 | -0.1149 | -0.0241 | -0.0206 |
| Free Cash Flow 1 | 327.2 | -14.1 | -596.2 | 38.7 | -12.25 | 23.32 |
| FCF margin | 166.81% | -1.55% | -73.07% | 4.39% | -1.82% | 2.13% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 4/23/18 | 4/29/19 | 7/9/20 | 4/28/21 | 4/28/22 | 4/26/23 |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 693 | 698 | 28.7 | 33.2 | 11.3 | 28.6 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | 327 | -14.1 | -596 | 38.7 | -12.2 | 23.3 |
| ROE (net income / shareholders' equity) | -13.9% | 1.98% | -0.8% | -16% | -3.73% | -3.29% |
| ROA (Net income/ Total Assets) | -2.75% | -0.9% | -1.24% | -8.7% | -2.05% | -1.75% |
| Assets 1 | 3,991 | -1,609 | 450 | 1,122 | 1,002 | 1,003 |
| Book Value Per Share 2 | 0.8600 | 0.8700 | 0.7800 | 0.6600 | 0.6400 | 0.6200 |
| Cash Flow per Share 2 | 0.0500 | 0.0300 | 0.0600 | 0.0600 | 0.0300 | 0.0400 |
| Capex 1 | 0.14 | 0.01 | - | - | - | 0.01 |
| Capex / Sales | 0.07% | 0% | - | - | - | 0% |
| Announcement Date | 4/23/18 | 4/29/19 | 7/9/20 | 4/28/21 | 4/28/22 | 4/26/23 |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -15.19% | 24.87M | |
| -2.29% | 371B | |
| +22.71% | 1.95B | |
| -18.03% | 1.07B | |
| +66.81% | 831M | |
| +9.13% | 803M | |
| -11.48% | 763M | |
| +44.37% | 670M | |
| -29.73% | 358M | |
| -10.21% | 287M |
- Stock Market
- Equities
- 6133 Stock
- Financials Vital Innovations Holdings Limited
